Related Experiment Video
Updated: Aug 1, 2026

10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.2K
Design and Evaluation of PROTACs Targeting Acyl Protein Thioesterase 1
Luís A R Carvalho1,2, Bárbara B Sousa1,2, Daniel Zaidman1
1Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW.
Chembiochem : a European Journal of Chemical Biology
|January 10, 2024
Summary
Computational software PRosettaC aids in designing Proteolysis Targeting Chimeras (PROTACs) by suggesting optimal alkyl linkers for targeting acyl protein thioesterase 1 (APT1), improving drug discovery efficiency.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Computational Biology
Background:
- PROTAC linker design is largely empirical.
- Acyl protein thioesterase 1 (APT1) is a target for therapeutic intervention.
- Developing efficient and selective PROTACs requires optimized linker strategies.
Purpose of the Study:
- To utilize computational software for rational PROTAC linker design.
- To investigate the efficacy and selectivity of sulfonyl-fluoride-based PROTACs targeting APT1.
- To evaluate the utility of PRosettaC in predicting PROTAC performance.
Main Methods:
- Employed PRosettaC computational software for PROTAC design.
- Generated ternary complex models to guide linker selection.
- Synthesized sulfonyl-fluoride-based PROTACs with suggested alkyl linkers.
- Assessed APT1 degradation using Western blotting.
- Determined PROTAC selectivity via activity-based protein profiling.
Main Results:
- PRosettaC efficiently generated ternary complex models.
- Alkyl linkers were identified as preferred for targeting APT1.
- Synthesized PROTACs demonstrated efficient APT1 degradation.
- An alkyl linker-based PROTAC exhibited high selectivity among serine hydrolases.
Conclusions:
- PRosettaC can effectively guide PROTAC linker design.
- Combining computational methods with chemoproteomics aids PROTAC development.
- This approach facilitates early-stage assessment of PROTAC potency and selectivity.

